Deallus thought leadership

The latest from Deallus pharmaceutical and life science industry experts

Gene therapy through different lenses

2019-11-08T11:15:00+00:00April 24th, 2019|Thought Piece|

After decades of clinical research and numerous setbacks, the promise of gene therapy is now much more than a glimmering hope on the horizon. Gene therapy is poised to revolutionize medicine as it presents the opportunity to remove or change the content of an individual’s genetic code in order to potentially treat or cure disease. We explore gene therapy from a few different lenses to give a full picture of where this innovation currently stands.

Head to head trials in elbow to elbow markets

2019-11-08T11:17:23+00:00March 16th, 2019|Thought Piece|

Head to head trials are proving to be a powerful mechanism for the testing of competitive medicines. A tactic for those already on the market who are eager to expand their market share, it offers the promise of considerable commercial advantage. We explore what needs to be known about head to head trials, and how they might be put to use for products operating in a saturated, competitive market.